Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $479,574 - $670,303
2,101 New
2,101 $669,000
Q4 2022

Feb 06, 2023

BUY
$205.95 - $280.43 $3.43 Million - $4.67 Million
16,646 New
16,646 $4.63 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Symmetry Investments LP Portfolio

Follow Symmetry Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Investments LP with notifications on news.